Sec Form 4 Filing - Laininger Dieter @ QUAKER CHEMICAL CORP - 2015-05-18

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Laininger Dieter
2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
VP & MD - SA & Primary Metals
(Last) (First) (Middle)
QUAKER CHEMICAL CORPORATION, ONE QUAKER PARK, 901 E. HECTOR STREET
3. Date of Earliest Transaction (MM/DD/YY)
05/18/2015
(Street)
CONSHOHOCKEN, PA19428-2380
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/18/2015 M 895 A $ 38.13 12,471 ( 1 ) D
Common Stock 05/18/2015 S 895 D $ 86.8704 ( 2 ) 11,576 D
Common Stock 05/18/2015 M 710 A $ 58.26 12,286 D
Common Stock 05/18/2015 S 710 D $ 86.7845 ( 3 ) 11,576 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 38.13 05/18/2015 M 895 ( 4 ) 03/06/2019 Common Stock 895 $ 0 0 D
Employee Stock Option (right to buy) $ 58.26 05/18/2015 M 710 ( 5 ) 03/05/2020 Common Stock 710 $ 0 710 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Laininger Dieter
QUAKER CHEMICAL CORPORATION
ONE QUAKER PARK, 901 E. HECTOR STREET
CONSHOHOCKEN, PA19428-2380
VP & MD - SA & Primary Metals
Signatures
Irene M. Kisleiko, Attorney-in-Fact for Dieter Laininger 05/20/2015
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Includes 10 shares acquired by reporting person on March 31, 2015 under the Company's Dividend Reinvestment Plan.
( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.3500 to $87.0600, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
( 3 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.4000 to $87.0000, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
( 4 )The options for this grant vested in three annual installments: 896 shares on March 6, 2013; 896 shares on March 6, 2014; and 895 shares on March 6, 2015.
( 5 )The options for this grant vest in three annual equal installments: 710 shares on March 5, 2014; 710 shares on March 5, 2015; and 710 shares on March 5, 2016.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.